You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ribonucleic acid (RNA) vaccine

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Influenza, Human Trial in United States (PF-07852352 Influenza saRNA 1, PF-07836391 Influenza saRNA, PF-07836394 Influenza

Recruiting
  • Influenza, Human
  • PF-07852352 Influenza saRNA 1
  • +10 more
  • Phoenix, Arizona
  • +23 more
Jan 17, 2023

BNT162b2 Messenger Ribonucleic Acid Covid-19 Vaccine in Cancer

Recruiting
  • Neoplasms
  • Cancer, Treatment-Related
  • BNT162b2 mRNA Covid-19 Vaccine
  • Genova, Italy
    E.O. Ospedali Galliera
Jun 18, 2021

Chronic Kidney Diseases, COVID-19 Trial in Scarborough, Toronto (Pfizer-BioNTech COVID-19 Vaccine, MODERNA SARS-CoV-2 Vaccine)

Active, not recruiting
  • Chronic Kidney Diseases
  • COVID-19
  • Pfizer-BioNTech COVID-19 Vaccine
  • MODERNA SARS-CoV-2 Vaccine
  • Scarborough, Ontario, Canada
  • +2 more
Aug 5, 2022

Melanoma, Colon Cancer, Gastrointestinal Cancer Trial run by the NCI (National Cancer Institute (NCI)-4650, a messenger

Terminated
Has Results
  • Melanoma
  • +4 more
  • National Cancer Institute (NCI)-4650, a messenger ribonucleic acid (mRNA)-based, Personalized Cancer Vaccine
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
May 22, 2020

COVID-19 Trial in Entebbe (LNP-nCOV saRNA-02 Vaccine)

Recruiting
  • COVID-19
  • LNP-nCOV saRNA-02 Vaccine
  • Entebbe, Uganda
    MRC/UVRI & LSHTM Uganda Research Unit
Apr 14, 2022

Covid19 Trial in Stockholm (Comirnaty (COVID-19, mRNA vaccine))

Active, not recruiting
  • Covid19
  • Comirnaty (COVID-19, mRNA vaccine)
  • Stockholm, Huddinge, Sweden
    Karolinska University Hospital
Sep 8, 2021

COVID-19, SARS-CoV-2 Trial in Indonesia, Mexico (SARS-CoV-2 mRNA Vaccine, Placebo)

Recruiting
  • COVID-19
  • SARS-CoV-2
  • SARS-CoV-2 mRNA Vaccine
  • Placebo
  • Jakarta, Indonesia
  • +11 more
Nov 10, 2021

Tuberculosis Trial (BNT164a1, BNT614b1, Placebo)

Not yet recruiting
  • Tuberculosis
  • BNT164a1
  • +2 more
  • (no location specified)
Jan 18, 2023

COVID-19, SARS-CoV-2 Trial in Johannesburg, Pretoria (GRT-R912, samRNA-Spikebeta-TCE11, GRT-R914, samRNA-Spikebeta-TCE9,

Recruiting
  • COVID-19
  • SARS-CoV-2
  • GRT-R912, samRNA-Spikebeta-TCE11
  • +2 more
  • Johannesburg, South Africa
  • +1 more
Jun 24, 2022

Tuberculosis Trial (BNT164a1, BNT614b1, Placebo)

Not yet recruiting
  • Tuberculosis
  • BNT164a1
  • +2 more
  • (no location specified)
Sep 8, 2022

Papillomavirus Infections, Coronavirus Disease (COVID-19) Trial in United States (9vHPV Vaccine, mRNA-1273 Vaccine)

Recruiting
  • Papillomavirus Infections
  • Coronavirus Disease (COVID-19)
  • 9vHPV Vaccine
  • mRNA-1273 Vaccine
  • Phoenix, Arizona
  • +37 more
Jan 18, 2023

Monkeypox Trial (BNT166a, BNT166c)

Not yet recruiting
  • Monkeypox
  • BNT166a
  • BNT166c
  • (no location specified)
Aug 4, 2023

Melanoma Trial in Germany (Lipo-MERIT)

Active, not recruiting
  • Melanoma
  • Lipo-MERIT
  • Frankfurt, Germany
  • +3 more
Jan 5, 2023

Human Immunodeficiency Virus Trial in Bangkok (Ad26.Mos.HIV, MVA-Mosaic, Placebo)

Completed
Has Results
  • Human Immunodeficiency Virus
  • Ad26.Mos.HIV
  • +2 more
  • Bangkok, Thailand
    (unnamed)
Dec 29, 2021

Rheumatoid Arthritis, Systemic Lupus Erythematosus (SLE), Pemphigus Vulgaris Trial in United States (Moderna mRNA-1273,

Recruiting
  • Rheumatoid Arthritis
  • +8 more
  • Moderna mRNA-1273
  • +5 more
  • Los Angeles, California
  • +24 more
Aug 17, 2022

Genital Herpes Simplex Type 2 Trial (BNT163, Placebo)

Not yet recruiting
  • Genital Herpes Simplex Type 2
  • BNT163
  • Placebo
  • (no location specified)
Jun 21, 2022

Environmental Factors on Transcriptomics Profile in Healthy

Recruiting
  • Healthy Volunteers
  • blood collection
  • Rostock, MV, Germany
    Centogene GmbH
Sep 13, 2023

SARS-CoV-2 Infection, COVID-19 Trial (BNT162b5 Bivalent or BNT162b2 Bivalent 30 µg, BNT162b4 5 µg, BNT162b4 10 µg)

Not yet recruiting
  • SARS-CoV-2 Infection
  • COVID-19
  • BNT162b5 Bivalent or BNT162b2 Bivalent 30 µg
  • +3 more
  • (no location specified)
Sep 14, 2022

Chronic Hepatitis, Hepatitis C Infection Trial in Puerto Rico, United States (Electroporation-Mediated Plasmid DNA Vaccine

Active, not recruiting
  • Chronic Hepatitis
  • Hepatitis C Infection
  • Electroporation-Mediated Plasmid DNA Vaccine Therapy
  • +4 more
  • Jacksonville, Florida
  • +4 more
Sep 20, 2022

Micro Ribonucleic Acid as Cholinergic Tone and Inflammatory

Completed
  • Inflammatory Bowel Disease
    • Tel Aviv, Israel
      Tel Aviv Sourasky Medical Center
    Jun 14, 2020

    Virologic Response in Participants Newly Diagnosed With HIV-1

    Completed
    • HIV
    • Antiretroviral Therapy
    • Lisboa, Portugal
      Chlo - Hosp. Egas Moniz
    Jan 17, 2023

    Covid19 Trial in Miami (BNT162b2 vaccine, JNJ-78436735 Vaccine)

    Active, not recruiting
    • Covid19
    • BNT162b2 vaccine
    • JNJ-78436735 Vaccine
    • Miami, Florida
      University of Miami
    Aug 1, 2022

    HIV-1 Infection Trial (DOR/ISL, BIC/FTC/TAF, Placebo to DOR/ISL)

    Not yet recruiting
    • HIV-1 Infection
    • (no location specified)
    Jan 20, 2023

    Human Immunodeficiency Virus Infections Trial in India (Rilpivirine 25 mg, Tenofovir Disoproxil Fumarate (TDF)/Lamivudine (3TC))

    Terminated
    • Human Immunodeficiency Virus Infections
    • Rilpivirine 25 mg
    • Tenofovir Disoproxil Fumarate (TDF)/Lamivudine (3TC)
    • Bengaluru, India
    • +5 more
    Jun 23, 2022

    Glioma, Malignant Trial in Durham (Tumor Associated Antigen Peptide Vaccine P30-EPS Vaccine, Hiltonol)

    Not yet recruiting
    • Glioma, Malignant
    • Tumor Associated Antigen Peptide Vaccine P30-EPS Vaccine
    • Hiltonol
    • Durham, North Carolina
      The Preston Robert Tisch Brain Tumor Center at Duke University
    Jan 19, 2023